Women’s health and beauty supplements market to reach $157.26 billion by 2030 at 11.7% CAGR, driven by rising disposable income supporting investment in personalized wellness products.
Read More
Wnt signaling pathway inhibitor market to reach $4.93 billion by 2030 at 9.7% CAGR, driven by rising demand for targeted therapies and increasing prevalence of chronic diseases.
Read More
Wilson’s disease drugs market to reach $0.9 billion by 2030 at 6.4% CAGR, driven by growing incidence of genetic disorders requiring long term copper regulation therapies.
Read More
Whey protein isolate market to reach $9.01 billion by 2030 at 8.6% CAGR, driven by increasing health and fitness awareness and adoption of high protein dietary patterns.
Read More
Wellness supplements market to reach $482.86 billion by 2030 at 8.6% CAGR, driven by increasing focus on healthy lifestyles and preventive nutrition practices.
Read More
Weight loss supplements market to reach $82.49 billion by 2030 at 11.7% CAGR, driven by rising living standards and disposable incomes boosting demand for health focused products.
Read More
Water soluble vitamin and mineral feed supplements market to reach $12.37 billion by 2030 at 13.0% CAGR, driven by growing meat consumption and demand for improved livestock nutrition.
Read More
Warts therapeutics market to reach $2.48 billion by 2030 at 4.5% CAGR, driven by rising accessibility to healthcare services supporting treatment of hpv related skin conditions.
Read More
Warm autoimmune hemolytic anemia treatment market to reach $0.93 billion by 2030 at 9.2% CAGR, driven by increasing healthcare expenditure enabling access to advanced diagnostics and therapies.
Read More
Vyndaqel market to reach $4.19 billion by 2030 at 17.1% CAGR, driven by growing adoption of precision medicine and rising healthcare expenditure for rare cardiac diseases.
Read More